Bliss GVS Pharma CEO steps down; new CEO and director appointed

Ceo ResignedCeo Appointed ExternalKmp ResignedManagement Changes View source PDF

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.6%1-day move

₹504.00

prior close

₹505.95

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.7+1.4+0.7+0.4+0.6+0.9+4.5+4.2+5.2+2.2-9.4———

Up moveDown movePending

AI summary

Bliss GVS Pharma announced a CEO transition. Mr. Narsimha Shibroor Kamath steps down as CEO effective July 14, 2026, but continues as Managing Director. Mr. Rahul Adakmol, an IIM Bangalore alumnus with 22 plus years of experience at Bharat Serums, Dr. Reddy's and Reliance, takes over as CEO from July 15. Also, Mr. Santosh Parab, a Chartered Accountant with 35 plus years of experience, joins as Additional Non-Executive Non-Independent Director.

Likely market impact

Leadership continuity maintained as outgoing CEO stays as MD; new CEO brings strong external pharma experience. Likely seen as a smooth, positive transition.